Trials / Sponsors / Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of Bomedemstat (MK-3543) in Participants With Polycythemia Vera (MK-3543-004) Polycythemia Vera | Phase 2 | 2023-09-07 |
| Completed | An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-72 Thrombocythemia, Essential, Primary Myelofibrosis | Phase 2 | 2021-12-15 |
| Completed | Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003) Essential Thrombocythemia | Phase 2 | 2020-09-08 |
| Completed | Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002) Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) | Phase 1 / Phase 2 | 2017-07-18 |
| Completed | A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Maligna Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 / Phase 2 | 2016-10-06 |